Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Leif William Ellisen, M.D.,Ph.D.


This page shows the publications co-authored by Leif Ellisen and Matthew Ramsey.
Connection Strength

  1. Ramsey MR, Wilson C, Ory B, Rothenberg SM, Faquin W, Mills AA, Ellisen LW. FGFR2 signaling underlies p63 oncogenic function in squamous cell carcinoma. J Clin Invest. 2013 Aug; 123(8):3525-38.
    View in: PubMed
    Score: 0.600
  2. Ramsey MR, Ellisen LW. Circadian function in cancer: regulating the DNA damage response. Proc Natl Acad Sci U S A. 2011 Jun 28; 108(26):10379-80.
    View in: PubMed
    Score: 0.520
  3. Ramsey MR, He L, Forster N, Ory B, Ellisen LW. Physical association of HDAC1 and HDAC2 with p63 mediates transcriptional repression and tumor maintenance in squamous cell carcinoma. Cancer Res. 2011 Jul 01; 71(13):4373-9.
    View in: PubMed
    Score: 0.515
  4. Ory B, Ramsey MR, Wilson C, Vadysirisack DD, Forster N, Rocco JW, Rothenberg SM, Ellisen LW. A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma. J Clin Invest. 2011 Feb; 121(2):809-20.
    View in: PubMed
    Score: 0.127
  5. Gallant-Behm CL, Ramsey MR, Bensard CL, Nojek I, Tran J, Liu M, Ellisen LW, Espinosa JM. ?Np63a represses anti-proliferative genes via H2A.Z deposition. Genes Dev. 2012 Oct 15; 26(20):2325-36.
    View in: PubMed
    Score: 0.036
  6. Harvey KF, Mattila J, Sofer A, Bennett FC, Ramsey MR, Ellisen LW, Puig O, Hariharan IK. FOXO-regulated transcription restricts overgrowth of Tsc mutant organs. J Cell Biol. 2008 Feb 25; 180(4):691-6.
    View in: PubMed
    Score: 0.026
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.